- Home
- LAAC vs PRGO Comparison
LAAC vs PRGO Comparison
Compare LAAC & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAAC
- PRGO
- Stock Information
- Founded
- LAAC 2007
- PRGO 1887
- Country
- LAAC Canada
- PRGO Ireland
- Employees
- LAAC N/A
- PRGO 9140
- Industry
- LAAC
- PRGO Biotechnology: Pharmaceutical Preparations
- Sector
- LAAC
- PRGO Health Care
- Exchange
- LAAC Nasdaq
- PRGO Nasdaq
- Market Cap
- LAAC 542.4M
- PRGO 3.5B
- IPO Year
- LAAC N/A
- PRGO 1991
- Fundamental
- Price
- LAAC $2.74
- PRGO $25.76
- Analyst Decision
- LAAC Hold
- PRGO Buy
- Analyst Count
- LAAC 3
- PRGO 4
- Target Price
- LAAC $5.58
- PRGO $37.00
- AVG Volume (30 Days)
- LAAC 1.3M
- PRGO 1.3M
- Earning Date
- LAAC 11-05-2024
- PRGO 11-06-2024
- Dividend Yield
- LAAC N/A
- PRGO 4.29%
- EPS Growth
- LAAC 3133.17
- PRGO N/A
- EPS
- LAAC 7.78
- PRGO N/A
- Revenue
- LAAC N/A
- PRGO $4,392,000,000.00
- Revenue This Year
- LAAC N/A
- PRGO N/A
- Revenue Next Year
- LAAC $208.49
- PRGO $4.51
- P/E Ratio
- LAAC $0.35
- PRGO N/A
- Revenue Growth
- LAAC N/A
- PRGO N/A
- 52 Week Low
- LAAC $2.07
- PRGO $23.89
- 52 Week High
- LAAC $6.69
- PRGO $34.60
- Technical
- Relative Strength Index (RSI)
- LAAC 36.55
- PRGO 36.42
- Support Level
- LAAC $2.69
- PRGO $25.16
- Resistance Level
- LAAC $3.21
- PRGO $28.62
- Average True Range (ATR)
- LAAC 0.17
- PRGO 0.66
- MACD
- LAAC -0.04
- PRGO -0.35
- Stochastic Oscillator
- LAAC 12.86
- PRGO 15.79
About LAAC Lithium Americas (Argentina) Corp.
Lithium Argentina is a pure-play lithium producer. The company owns two neighboring lithium brine resources in northwest Argentina: Cauchari-Olaroz and Pastos Grandes. Cauchari-Olaroz entered production in 2023, while Pastos Grandes is still in development. Lithium Argentina plans for both resources to be fully integrated with onside downstream processing capabilities and will sell into the lithium chemical market.
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.